Boston Therapeutics Inc (OTCQB:BTHE)

0.20
Delayed Data
As of Jul 28
 0.00 / 0.00%
Today’s Change
0.08
Today|||52-Week Range
0.80
-69.17%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues4.1K42.3K323.4K199.6K
 
 
 
 
 
Cost of Goods Sold6.4K56.9K211.1K104.9K
 
 
 
 
 
Depreciation And Amortization64.3K65.0K67.1K70.9K
 
 
 
 
 
 
Operating ExpensesGross Income-66.5K-79.6K45.2K23.8K
 
 
 
 
 
General Expenses745.0K1.4M4.6M4.7M
 
 
 
 
 
Research And Development130.0K114.0K542.5K1.4M
 
 
 
 
 
Total Operating Expenses815.6K1.5M4.9M4.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-811.5K-1.5M-4.6M-4.7M
 
 
 
 
 
Interest Expense On Debt15.7K18.4K19.7K20.0K
 
 
 
 
 
Other Expenses0.00-3.2K-1.6K-5.6K
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-827.2K-1.5M-4.6M-4.7M
 
 
 
 
 
Net Income-827.2K-1.5M-4.6M-4.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS15.1M16.9M25.4M38.2M
 
 
 
 
 
Shares To Calculate EPS Diluted15.1M16.9M25.4M38.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.05-$0.09-$0.18-$0.12
 
 
 
 
 
EPS Diluted-$0.05-$0.09-$0.18-$0.12
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account